Use of contrast material improves aortic valve assessment during echocardiography: a study

Published Date: 10 Mar 2023

United States: The US research team recommended using a different agent to enhance the Doppler profile for more accurate measurements.

Read Full News

Latest News

S3 Episode 4: Cannabis and Medicinal Mushrooms in Cancer Survivorship

Drs Kathryn J. Ruddy and Stacy D. D'Andre discuss when cannabis, medicinal mushrooms, and psychedelic mushrooms may be useful for treating specific symptoms in patients with cancer.

Aug 08 2025 This Week in Cardiology

Listener feedback on SURPASS CVOT, AF ablation and the limits of meta-analyses, a Watchman alert from FDA, and oral anticoagulation choices in elderly patients are discussed by John Mandola, MD, in this week’s podcast.

Episode 4: A Surgeon's Guide to Hidradenitis Suppurativa

Join surgeon Dr Julie Caffrey as she shares her approach to hidradenitis suppurativa surgery, from patient selection to excision, reconstruction, and reducing recurrence.

Jul 18 2025 This Week in Cardiology

Finerenone, what not to consider when choosing treatment of AS, brain health after atrial fibrillation ablation, early rhythm control for AF, and Watchman reimbursement cuts are discussed by John Mandrola, MD, in this week’s podcast.

May 30 2025 This Week in Cardiology

Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are the topics John Mandrola, MD, discusses in this week’s podcast.

May 23 2025 This Week in Cardiology

Listener feedback on sports “disqualification,” big digoxin news, Brugada syndrome, another positive finerenone study, and unblinded transcatheter trials are discussed by John Mandrola, MD, in this week’s podcast.

Todays Updates

CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis Marco Meglio

New phase 3 FREXCITE trial tests frexalimab CD40L inhibitor in nrSPMS, comparing on-body subcutaneous vs IV dosing

Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers Marco Meglio

Findings from a phase 1 study indicated that Lucid-21-302 was generally well tolerated and exhibited dose-proportional exposure, warranting additional study in a phase 2 trial for multiple sclerosis.

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Todays Updates

CD40L Inhibitor Frexalimab Enters Phase 3 FREXITE Trial of Non-Relapsing Secondary Progressive Multiple Sclerosis Marco Meglio

New phase 3 FREXCITE trial tests frexalimab CD40L inhibitor in nrSPMS, comparing on-body subcutaneous vs IV dosing

Myelin Protective Small Molecule Lucid-MS Shows Promising Early-Stage Data in Healthy Volunteers Marco Meglio

Findings from a phase 1 study indicated that Lucid-21-302 was generally well tolerated and exhibited dose-proportional exposure, warranting additional study in a phase 2 trial for multiple sclerosis.

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Oral Semaglutide May Reduce Heart Failure Risk in Patients With T2D

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Upadacitinib Switch from Dupilumab Effective in Head and Neck Atopic Dermatitis

Latest News

Drs Kathryn J. Ruddy and Stacy D. D'Andre discuss when cannabis, medicinal mushrooms, and psychedelic mushrooms may be useful for treating specific symptoms in patients with cancer.

Listener feedback on SURPASS CVOT, AF ablation and the limits of meta-analyses, a Watchman alert from FDA, and oral anticoagulation choices in elderly patients are discussed by John Mandola, MD, in this week’s podcast.

Join surgeon Dr Julie Caffrey as she shares her approach to hidradenitis suppurativa surgery, from patient selection to excision, reconstruction, and reducing recurrence.

Finerenone, what not to consider when choosing treatment of AS, brain health after atrial fibrillation ablation, early rhythm control for AF, and Watchman reimbursement cuts are discussed by John Mandrola, MD, in this week’s podcast.

Listener feedback, CRT vs CSP, important clues on the ECG, beta-blocker interruption after myocardial infarction, novel approaches to LDL-C lowering, and ICD decisions in cardiac sarcoidosis are the topics John Mandrola, MD, discusses in this week’s podcast.

Listener feedback on sports “disqualification,” big digoxin news, Brugada syndrome, another positive finerenone study, and unblinded transcatheter trials are discussed by John Mandrola, MD, in this week’s podcast.

News All Time

The Dual Role of Illusion in Patient Care

From painted leaves to placebos, we must balance hope and honesty

The Global Applicability of the DanGer Shock Trial

Positive results were shown for implantation of a mechanical circulatory support device plus standard care for patients presenting with cardiogenic shock and STEMI.

Surprising Mediator Links Poverty and Knee Pain

Study: It's not deprivation per se, but intervening factors that go with it

Sodium Channel Blocker Relieves Acute Pain in Phase III Data

Trials favor a first new class of pain drug in years

No X-Ray Proof of Rare Surgical Complication Tied to GLP-1 Agonists

Conundrum of holding meds continues following conflicting reports of aspiration events

Deep Neuromuscular Blockade Helps Keyhole Surgery, but Not Outcomes Per Se

No impact on safety outcomes after laparoscopic surgery

Stable Angina: A Patient-Centered Approach

A review of the complementary role of coronary revascularization, optimal medical therapy, and lifestyle interventions in the management of stable angina, and the importance of an approach that targets the pathobiology.

Food Retention Risk Low for GLP-1 Users When Endoscopy Is Combined With Colonoscopy

Bowel preparation protocols appeared protective in small study

Sep 27 2024 This Week in Cardiology

Surgical clearance, NICM assessment, dueling perspectives on PCI as first-line therapy for angina, GDMT in HFrEF are the topics John Mandrola, MD, discusses in this week?s podcast.

S2 Episode 5: The Complex Patient With Pulmonary Hypertension and ILD

Drs Jeffrey Swigris and M. Patricia George discuss the complexities of diagnosing and treating pulmonary hypertension in patients with interstitial lung disease.

Laboratory and Radiologic Tests When Assessing a Patient With HF

Dr Kittleson uses the universal heart failure definition to assess symptoms, relying on echocardiograms and natriuretic peptides for diagnosis and classification.

Sep 13 2024 This Week in Cardiology

More from ESC: the SCOFF trial and fasting before cardiac cath, MATTERHORN, humbling data with AI, plus a reflection on the work of being a patient are the topics John Mandrola, MD, covers this week.

Impact of Lp(a) on LDL-C or Apo-B-related Risk of CAD

A comparison of the association between LDL-C and LDL-C corrected for Lp(a)-C (LDLLp(a)corr) with incident coronary heart disease.

Inducing General Anesthesia From the Doctor's Point of View

Watch from the perspective of an anesthesiologist as he prepares a patient to go under the knife

What the Matthew Perry Tragedy Reminds Us About Ketamine Use

We must develop multi-disciplinary safety standards for ketamine clinics

HDL Parameters and Risk of Heart Failure

The association between HDL particle concentration and size with heart failure is studied in participants from the ARIC, MESA, PREVEND, and Dallas Heart studies.

Recommended News For You

Early palliative care billing up from 2010 to 2019 for advanced cancer

Skinny melanoma incidence is associated with vitamin D deficiency.

Scientists identify dual protein targets to weaken pancreatic cancer defenses

AI could help improve early detection of interval breast cancers

Review looks at potential treatment targets in the tumor microenvironment.

Adult overdose deaths on the rise

Cabozantinib Improves PFS for Advanced Neuroendocrine Tumors

Recommended Articles For You

Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches 

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment 

A Closer Look at the Effects of Sickle Cell on Eyesight 

How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Medical Journal March 28, 2023

2.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

3.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

4.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

5.

Pancreatic Cancer: A Novel CD40 Agonist-Chemo Combo Shows Promise.

1.

Protein S-Palmitoylation in Cancer: A Novel Target in Immunotherapy & Treatment

2.

The Statistical Evolution of Cancer Staging and Its Precision Impact on Prognosis and Therapy in Cancer Staging 2025

3.

From Birthmarks to Tumors: The Science Behind Infantile Hemangioma 

4.

Case Study: The Role of Machine Learning in the Detection of Skin Cancer

5.

Precision Oncology: Cancer Screening, Genetic Counseling & Hereditary Cancer Syndromes Integration

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

3.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Navigating the Complexities of Ph Negative ALL - Part XIV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot